This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Cancer Biological Therapy Market

Market Insights on Cancer Biological Therapy covering sales outlook, demand forecast & up-to-date key trends

Cancer Biological Therapy market by Product Type, Vehicle Type, Sales Channel & Region | Forecast 2022 to 2032.

Cancer Biological Therapy Market Overview (2022 to 2032)

The global Cancer Biological Therapy Market was valued at around US$ 90.9 Billion at the end of 2021. The market is projected to register a 7.8 % CAGR and top a valuation of US$ 209.8 Billion by 2032.

In the upcoming years, the global market for cancer biological therapies is anticipated to grow at a crucial rate. Effective government policies in developed countries for cancer therapy are the main factor that is projected to drive the global market for cancer biological therapies.

Cancer biological therapy is a sophisticated method of cancer treatment that makes use of a live organism. These life forms are either produced in a lab to cure a cancer infection or obtained from living cells. There are many different kinds of biological treatments, some of which include monoclonal antibodies, interleukins, interferon, and vaccinations. The therapy essentially combats cancer by directly or indirectly making use of the body's immune system. The global market for cancer biological therapy is expected to grow as a result of the rising incidence of cancer cases and the number of specialized cancer treatment facilities around the world.

In economically developed nations, 58% of all newly diagnosed cancer cases happen in patients 65 years of age or older, compared to 40% in developing nations, says globocan. Cancer is the third major cause of mortality in low- and middle-income countries and the second leading cause of death in high-income countries when countries are categorized according to income.

Attributes

Details

Cancer biological therapy market value in 2021

US$ 90.9 Billion

Cancer biological therapy market value in 2032

US$ 209.8 Billion

Cancer biological therapy market CAGR (2022 to 2032)

7.8 %

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Major Drivers Boosting the Demand for Cancer Biological Therapy?

Growing demand for cancer biological therapy market due to increasing education and awareness in the upcoming few years, it is anticipated that the global market for cancer biological therapies would expand quickly. This is attributable to an increase in funding for advanced therapeutic research and development by several public and commercial organizations. Furthermore, the global market for cancer biological therapies is projected to be driven by favorable government policies in industrialized nations for the treatment of cancer.

The rising prevalence of diseases is projected to increase the need for treatment and fuel industrial expansion. Additionally, increased exposure to external carcinogens as well as rising alcohol and tobacco use will raise the risk of getting cancer which will drive up market demand for cancer biological therapy.

The World Health Organization (WHO) has reported that the burden of cancer is rapidly rising globally, increasing the need for cancer biological therapy. The market has grown because of the world's aging population. Since biological therapy for the treatment of cancer uses a targeted approach without doing much harm to the nearby healthy cells in the body, it has become more popular than other chemotherapies on the market.

Which Region Shows Strong Growth Potential in the Cancer Biological Therapy Market?

The Cancer Biological Therapy Market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

During the projection period, North America is anticipated to have a significant market share for cancer biological therapies worldwide. This is attributable to the region's extensive player base and well-developed healthcare system.

During the projection period, substantial growth in the Asia Pacific market for cancer biological therapies is anticipated. The region's cancer biological therapy market is expected to develop faster than average due to the rising cancer burden, the vast patient pool, and improvements in cancer therapy. Furthermore, the market for cancer biological therapy in the Asia Pacific is anticipated to grow over the next years as a result of fast-increasing molecular biology techniques, the complexity of health care, technology improvements, and creative approaches.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Players in the Cancer Biological Therapy Market?

F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GSK plc, Novartis AG, Bayer AG, Lilly, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, Endo Pharmaceuticals plc, Zydus Group, Bausch Health Companies Inc., among others.

Scope of Report

Report Attributes

Details

Growth Rate

CAGR of 7.8 % from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2012 to 2021

Forecast Period

2022 to 2032

Qualitative Units

Revenue in USD Million, and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

Segment Covered

  • By Therapy Type
  • By Route of Administration
  • By Cancer Type
  • By End User
  • By Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Israel

Key Players

  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi, Pfizer Inc.
  • GSK plc
  • Novartis AG
  • Bayer AG
  • Lilly
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma
  • Lupin
  • Endo Pharmaceuticals plc
  • Zydus Group
  • Bausch Health Companies Inc.
  • Others

Customization

Available Upon Request

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Key Segments Covered in the Cancer Biological Therapy Market Report

By Therapy Type:

  • Gene Therapy
  • Monoclonal Antibody Therapy
  • Vaccines Therapy
  • Targeted Drug Therapy
  • Bio chemotherapy
  • Cancer Growth Blockers
  • Others

By Route of Administration:

  • Intravenous
  • Subcutaneous
  • Intrathecal
  • Intramuscular

By Cancer Type:

  • Pancreatic Cancer
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

By End User:

  • Hospitals
  • Specialty Clinics
  • Cancer Research Centres
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The market is likely to register a CAGR of 5.5% through 2032.

The market is currently valued at US$ 54.01 Billion in 2022.

The market is likely to grow to a valuation of US$ 92.26 Billion by 2032.

Asia Pacific is likely to be a leading market during the forecast period.

Table of Content

NA
Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cancer Antigens Market

Published : October 2019

Healthcare

Colorectal Cancer Molecular Diagnostics Market

Published : January 2019

Healthcare

Molecular Diagnostics Market

Published : February 2016

Healthcare

Cancer Diagnostics Market

Published : March 2021

Google translate

Cancer Biological Therapy Market